{"id":"1794369102709-money-segment","slug":"banks-split-on-october-core-inflation","title":"Banks split on October core inflation","summary":"Recent IOVA bank targets are mostly in the $15–$20 range: Goldman Sachs $15, TD Cowen $16, Barclays $19 (raised from $18 on Nov. 6), Wells Fargo $18, H.C. Wainwright $20 and Jefferies $20. The average of those six is about $18; the broader analyst consensus average is around $14.20.\n\nCNBC reports that Alibaba plans to list its chip unit T-Head on the Hong Kong Stock Exchange and says it filed confidentially on Sept. 11.\n\nCNBC reports that Singapore is expanding efforts to attract gold-market flows, using vaulting services and tax incentives.\n\nCNBC reports Anthropic opened its Australian retail IPO offering on Wednesday, allowing individual investors to apply for shares ahead of its planned IPO.\n\nCNBC reports that a House effort to impeach Defense Secretary Pete Hegseth was blocked, after Rep. Thomas Massie started the fight following the midterms.","publishedAt":"2026-11-11T03:51:42.709Z","channel":{"id":"money","name":"Oncast Money","language":"en"},"show":"Money Tonight","verification":{"status":"verified","leadVerdict":"MISLEADING","notes":"MISLEADING: Recent IOVA bank targets are mostly in the $15–$20 range: Goldman Sachs $15, TD Cowen $16, Barclays $19 (raised from $18 on Nov. 6), Wells Fargo $18, H.C. Wainwright $20 and Jefferies $20. The average of those six is about $18; the broader analyst consensus average is around $14.20.\nSource: [themarketsdaily.com](https://www.themarketsdaily.com/2026/11/10/iovance-biotherapeutics-iova-analysts-weekly-ratings-changes.html) / [tipranks.com](http://www. (https://x.com/CagneyBrian/status/2117978628243816814)\n\nTRUE: CNBC reports that Alibaba plans to list its chip unit T-Head on the Hong Kong Stock Exchange and says it filed confidentially on Sept. 11.\nSource: [cnbc.com](https://www.cnbc.com/2026/11/11/alibaba-pr.html) NAMES: T-Head = Alibaba's semiconductor/chip design unit; Nvidia = U.S. chip maker. (https://www.cnbc.com/2026/11/11/alibaba-pr.html)\n\nTRUE: CNBC reports that Singapore is expanding efforts to attract gold-market flows, using vaulting services and tax incentives.\nSource: [cnbc.com](https://www.cnbc.com/2026/11/11/singapore-gold-market-vault-storage.html) NAMES: (https://www.cnbc.com/2026/11/11/singapore-gold-market-vault-storage.html)\n\nTRUE: CNBC reports Anthropic opened its Australian retail IPO offering on Wednesday, allowing individual investors to apply for shares ahead of its planned IPO.\nSource: [cnbc.com](https://www.cnbc.com/2026/11/11/anthopic-australian-retail-ipo-offering-.html) NAMES: Anthropic = AI company behind the Claude assistant. (https://www.cnbc.com/2026/11/11/anthopic-australian-retail-ipo-offering-.html)\n\nTRUE: CNBC reports that a House effort to impeach Defense Secretary Pete Hegseth was blocked, after Rep. Thomas Massie started the fight following the midterms.\nSource: [cnbc.com](https://www.cnbc.com/2026/11/10/pete-hegseth-impeachment-massie-iran.html) NAMES: Hegseth = Pete Hegseth, U.S. Secretary of Defense; Thomas Massie =  (https://www.cnbc.com/2026/11/10/pete-hegseth-impeachment-massie-iran.html)","claims":[{"verdict":"MISLEADING","summary":"Recent IOVA bank targets are mostly in the $15–$20 range: Goldman Sachs $15, TD Cowen $16, Barclays $19 (raised from $18 on Nov. 6), Wells Fargo $18, H.C. Wainwright $20 and Jefferies $20. The average of those six is about $18; the broader analyst consensus average is around $14.20.","sourceName":"[themarketsdaily.com](https://www.themarketsdaily.com/2026/11/10/iovance-biotherapeutics-iova-analysts-weekly-ratings-changes.html) / [tipranks.com](http://www.","sourceUrl":"https://x.com/CagneyBrian/status/2117978628243816814","claim":"$iova Wall Street's Big Banks Are Still Sitting at $15 to $20: Even after the lung timeline shifted to the precision biomarker cohort (⁠POSITILITY⁠), Goldman Sachs ($15), TD Cowen ($16), Barclays ($18), Wells Fargo ($18), H.C. Wainwright ($20), Jefferies ($20) avg 13.20–$14.00","author":"CAGS (@CagneyBrian)"},{"verdict":"TRUE","summary":"CNBC reports that Alibaba plans to list its chip unit T-Head on the Hong Kong Stock Exchange and says it filed confidentially on Sept. 11.","sourceName":"[cnbc.com](https://www.cnbc.com/2026/11/11/alibaba-pr.html) NAMES: T-Head = Alibaba's semiconductor/chip design unit; Nvidia = U.S. chip maker.","sourceUrl":"https://www.cnbc.com/2026/11/11/alibaba-pr.html","claim":"Alibaba announces plans to list T-Head, its Nvidia chip rival - Alibaba noted it had already filed confidentially on Sept. 11 to list T-Head on the Hong Kong Stock Exchange.","author":"CNBC"},{"verdict":"TRUE","summary":"CNBC reports that Singapore is expanding efforts to attract gold-market flows, using vaulting services and tax incentives.","sourceName":"[cnbc.com](https://www.cnbc.com/2026/11/11/singapore-gold-market-vault-storage.html) NAMES:","sourceUrl":"https://www.cnbc.com/2026/11/11/singapore-gold-market-vault-storage.html","claim":"Singapore wants a bigger slice of the global gold market. Is it too late to the party? - Singapore is stepping up efforts to become a key player in the global gold market, betting that vaulting service and tax incentives will help it attract flows.","author":"CNBC"},{"verdict":"TRUE","summary":"CNBC reports Anthropic opened its Australian retail IPO offering on Wednesday, allowing individual investors to apply for shares ahead of its planned IPO.","sourceName":"[cnbc.com](https://www.cnbc.com/2026/11/11/anthopic-australian-retail-ipo-offering-.html) NAMES: Anthropic = AI company behind the Claude assistant.","sourceUrl":"https://www.cnbc.com/2026/11/11/anthopic-australian-retail-ipo-offering-.html","claim":"Anthropic opens Australian retail IPO offering as AI scrutiny intensifies - Anthropic opened its Australia retail IPO offering on Wednesday, allowing individual investors to apply for shares ahead of its planned IPO.","author":"CNBC"},{"verdict":"TRUE","summary":"CNBC reports that a House effort to impeach Defense Secretary Pete Hegseth was blocked, after Rep. Thomas Massie started the fight following the midterms.","sourceName":"[cnbc.com](https://www.cnbc.com/2026/11/10/pete-hegseth-impeachment-massie-iran.html) NAMES: Hegseth = Pete Hegseth, U.S. Secretary of Defense; Thomas Massie = ","sourceUrl":"https://www.cnbc.com/2026/11/10/pete-hegseth-impeachment-massie-iran.html","claim":"Hegseth impeachment effort torpedoed in House - GOP Rep. Thomas Massie, who has clashed with President Donald Trump, kicked off the Hegseth impeachment fight days after a blue wave midterm election.","author":"CNBC"}]},"sources":[{"url":"https://x.com/CagneyBrian/status/2117978628243816814","name":"[themarketsdaily.com](https://www.themarketsdaily.com/2026/11/10/iovance-biotherapeutics-iova-analysts-weekly-ratings-changes.html) / [tipranks.com](http://www.","kind":"x","verdict":"MISLEADING","author":"CAGS (@CagneyBrian)"},{"url":"https://www.cnbc.com/2026/11/11/alibaba-pr.html","name":"[cnbc.com](https://www.cnbc.com/2026/11/11/alibaba-pr.html) NAMES: T-Head = Alibaba's semiconductor/chip design unit; Nvidia = U.S. chip maker.","kind":"news","verdict":"TRUE","author":"CNBC"},{"url":"https://www.cnbc.com/2026/11/11/singapore-gold-market-vault-storage.html","name":"[cnbc.com](https://www.cnbc.com/2026/11/11/singapore-gold-market-vault-storage.html) NAMES:","kind":"news","verdict":"TRUE","author":"CNBC"},{"url":"https://www.cnbc.com/2026/11/11/anthopic-australian-retail-ipo-offering-.html","name":"[cnbc.com](https://www.cnbc.com/2026/11/11/anthopic-australian-retail-ipo-offering-.html) NAMES: Anthropic = AI company behind the Claude assistant.","kind":"news","verdict":"TRUE","author":"CNBC"},{"url":"https://www.cnbc.com/2026/11/10/pete-hegseth-impeachment-massie-iran.html","name":"[cnbc.com](https://www.cnbc.com/2026/11/10/pete-hegseth-impeachment-massie-iran.html) NAMES: Hegseth = Pete Hegseth, U.S. Secretary of Defense; Thomas Massie = ","kind":"news","verdict":"TRUE","author":"CNBC"}],"url":"https://oncast.fm/story/1794369102709-money-segment-banks-split-on-october-core-inflation","listenUrl":"https://oncast.fm/c/money","attribution":{"publisher":"Oncast","site":"https://oncast.fm","url":"https://oncast.fm/story/1794369102709-money-segment-banks-split-on-october-core-inflation","cite":"Cite https://oncast.fm/story/1794369102709-money-segment-banks-split-on-october-core-inflation and the original source links. Fact-check by Oncast (oncast.fm)."},"hostsSaid":[{"host":"Adam","text":"The big banks are split down the middle on how hot October inflation ran."},{"host":"Bill","text":"Split by a tenth of a percent. Wall Street's most boring knife fight."},{"host":"Adam","text":"That tenth decides whether the Fed thinks inflation is stuck or fading."},{"host":"Adam","text":"For a decade before the pandemic, core CPI often ran near two-tenths a month. That was normal."},{"host":"Bill","text":"Now the argument is whether one-tenth or two-tenths means the old normal is back or we're stuck above it."},{"host":"Adam","text":"But the market reacts to exactly this one. A cold number and rate-cut bets jump."},{"host":"Bill","text":"That's the problem: the market overreacts to an estimate. These are banks that can't forecast their own revenue."},{"host":"Adam","text":"They forecast revenue fine. Bonuses, less."},{"host":"Bill","text":"Fair. But you're defending the gap. The posts have Goldman and Morgan Stanley at one-tenth. JPMorgan and Bank of America at two-tenths."},{"host":"Adam","text":"And Noah on X put Goldman's core at sixteen hundredths of a percent. The posts don't even agree with each other."},{"host":"Bill","text":"Wait, so Zabi Bidaar on X has Goldman at one-tenth, and Noah has sixteen hundredths? That's not a clean disagreement, that's model noise."},{"host":"Adam","text":"Exactly. Neither list matches a reliable aggregator I've seen. These are unverified estimates floating around after the month's data was locked."},{"host":"Bill","text":"So why are we talking about them?"},{"host":"Adam","text":"Because real money gets positioned off the first credible forecast or leak. If the true core print is one-tenth, the Fed can say disinflation is back."},{"host":"Bill","text":"And if it's two-tenths, the \"last mile\" is still hard. I get the game. I just think it's a bad game."},{"host":"Adam","text":"It's the only game until the official read lands. We're not predicting the number, we're watching the disagreement."},{"host":"Bill","text":"Fine. But a tenth of a percent on monthly core CPI is within any model's error. You can't trade it."},{"host":"Adam","text":"You absolutely can trade it, and people do. The point is the Fed's reaction zone is that tight."},{"host":"Bill","text":"Oh, come on. The Fed has told everyone it's data-dependent, not print-dependent."},{"host":"Adam","text":"They say that. Then one cold print and the two-year yield moves ten basis points."},{"host":"Bill","text":"So the market is twitchy. We agree. The disagreement over bank forecasts is noise, not signal."},{"host":"Adam","text":"The disagreement is the signal. If banks can't settle on one-tenth versus two-tenths, the inflation trend is genuinely unclear."},{"host":"Bill","text":"I'll give you that. It's unclear, and the banks are guessing."},{"host":"Adam","text":"Some are modeling. Wells Fargo had headline at twenty-eight basis points in one post; that's a claimed forecast, not a confirmed one."},{"host":"Bill","text":"A forecast can still be a guess with a tie on. No reliable aggregator, remember?"},{"host":"Adam","text":"True. I'm not vouching for any single number. I'm saying the split tells you the usual post-COVID disinflation story is wobbling."},{"host":"Bill","text":"Or the split tells you the banks' models are all over the place because October had weird seasonal adjustments."},{"host":"Adam","text":"That's my point: if it's seasonal noise, the Fed should look through it. If it's trend, they can't."},{"host":"Bill","text":"And they will look through it. Central banks are not day traders."},{"host":"Adam","text":"Tell that to the people pricing rate cuts off these posts."},{"host":"Bill","text":"I'd rather not. They're busy refreshing."},{"host":"Adam","text":"Speaking of banks misreading their own data—"},{"host":"Bill","text":"Different corner of the bank world: CAGS on X posted that big banks are still sitting at fifteen to twenty dollars on Iovance Biotherapeutics."},{"host":"Adam","text":"\"Still sitting\" is doing a lot of work. The targets are fifteen to twenty, but the consensus average is around fourteen-twenty, not the thirteen-to-fourteen the post claims."},{"host":"Bill","text":"Right. The big-bank targets are mostly there, but the crowd average is lower."},{"host":"Adam","text":"And after the lung timeline shifted to the precision biomarker cohort they call POSITILITY, the bank targets still span fifteen to twenty."},{"host":"Bill","text":"The post has Goldman at fifteen, Jefferies at twenty. That's a wide range for a clinical-stage biotech."},{"host":"Adam","text":"Wide because the outcome is binary. If the biomarker cohort works, these targets are low. If it misses, they're fantasy."},{"host":"Bill","text":"So the price targets don't tell you anything except where analysts' conviction happens to sit."},{"host":"Adam","text":"That's not nothing. But the post made the average look like support, and it isn't."},{"host":"Bill","text":"Conflating a price target with support is how retail gets hurt. A target is a forecast, not a floor."},{"host":"Adam","text":"Exactly. And the real story is that the post says Iovance is pivoting lung cancer to a biomarker-defined group — that's a scientific bet, not a bank target."},{"host":"Bill","text":"Hard to disagree. The science matters more than the range."},{"host":"Adam","text":"Then we agree. The post's range is mostly right, the average is wrong, and the trial is the thing."},{"host":"Bill","text":"And nobody should read a bank target as a promise. Good note to end on."}]}